DISEASES INFORMATIONS CORNER

Genes essential for the proper muscle development identified


Tiny DNA Molecules Show Liquid Crystal Phases, Pointing Up New Scenario For First Life On Earth

A team led by the University of Colorado at Boulder and the University of Milan has discovered some unexpected forms of liquid crystals of ultrashort DNA molecules immersed in water, providing a new scenario for a key step in the emergence of life on Earth

A colorful microscope image showing that a solution of tiny DNA molecules has formed a liquid-crystal phase. The DNA molecules pair to form DNA double helices, which, in turn stack end-to-end to make rod-shaped aggregates that orient parallel to one another. (Credit: Michi Nakata)

CU-Boulder physics Professor Noel Clark said the team found that surprisingly short segments of DNA, life’s molecular carrier of genetic information, could assemble into several distinct liquid crystal phases that “self-orient” parallel to one another and stack into columns when placed in a water solution. Life is widely believed to have emerged as segments of DNA- or RNA-like molecules in a prebiotic “soup” solution of ancient organic molecules.

Since the formation of molecular chains as uniform as DNA by random chemistry is essentially impossible, Clark said, scientists have been seeking effective ways for simple molecules to spontaneously self-select, “chain-up” and self-replicate. The new study shows that in a mixture of tiny fragments of DNA, those molecules capable of forming liquid crystals selectively condense into droplets in which conditions are favorable for them to be chemically linked into longer molecules with enhanced liquid crystal-forming tendencies, he said.

“We found that even tiny fragments of double helix DNA can spontaneously self-assemble into columns that contain many molecules,” Clark said. “Our vision is that from the collection of ancient molecules, short RNA pieces or some structurally related precursor emerged as the molecular fragments most capable of condensing into liquid crystal droplets, selectively developing into long molecules.”

Liquid crystals — organic materials related to soap that exhibit both solid and liquid properties — are commonly used for information displays in computers, flat-panel televisions, cell phones, calculators and watches. Most liquid crystal phase molecules are rod-shaped and have the ability to spontaneously form large domains of a common orientation, which makes them particularly sensitive to stimuli like changes in temperature or applied voltage.

RNA and DNA are chain-like polymers with side groups known as nucleotides, or bases, that selectively adhere only to specific bases on a second chain. Matching, or complementary base sequences enable the chains to pair up and form the widely recognized double helix structure. Genetic information is encoded in sequences of thousands to millions of bases along the chains, which can be microns to millimeters in length.

Such DNA polynucleotides had previously been shown to organize into liquid crystal phases in which the chains spontaneously oriented parallel to each other, he said. Researchers understand the liquid crystal organization to be a result of DNA’s elongated molecular shape, making parallel alignment easier, much like spaghetti thrown in a box and shaken would be prone to line up in parallel, Clark said.

A paper on the subject was published in the Nov. 23 issue of Science. The paper was authored by Clark, Michi Nakata and Christopher Jones from CU-Boulder, Giuliano Zanchetta and Tommaso Bellini of the University of Milan, Brandon Chapman and Ronald Pindak of Brookhaven National Laboratory and Julie Cross of Argonne National Laboratory. Nakata died in September 2006.

The CU-Boulder and University of Milan team began a series of experiments to see how short the DNA segments could be and still show liquid crystal ordering, said Clark. The team found that even a DNA segment as short as six bases, when paired with a complementary segment that together measured just two nanometers long and two nanometers in diameter, could still assemble itself into the liquid crystal phases, in spite of having almost no elongation in shape.

Structural analysis of the liquid crystal phases showed that they appeared because such short DNA duplex pairs were able to stick together “end-to-end,” forming rod-shaped aggregates that could then behave like much longer segments of DNA. The sticking was a result of small, oily patches found on the ends of the short DNA segments that help them adhere to each other in a reversible way — much like magnetic buttons — as they expelled water in between them, Clark said.

A key characterization technique employed was X-ray microbeam diffraction combined with in-situ optical microscopy, carried out with researchers from Argonne and Brookhaven National Laboratories. The team using a machine called the Argonne Advanced Photon Source synchrotron that enabled probing of the “nano DNA” molecular organization in single liquid crystal orientation domains only a few microns in size. The experiments provided direct evidence for the columnar stacking of the nano DNA pieces in a fluid liquid crystal phase.

“The key observation with respect to early life is that this aggregation of nano DNA strands is possible only if they form duplexes,” Clark said. “In a sample of chains in which the bases don’t match and the chains can’t form helical duplexes, we did not observe liquid crystal ordering.”

Subsequent tests by the team involved mixed solutions of complementary and noncomplementary DNA segments, said Clark. The results indicated that essentially all of the complementary DNA bits condensed out in the form of liquid crystal droplets, physically separating them from the noncomplementary DNA segments.

“We found this to be a remarkable result,” Clark said. “It means that small molecules with the ability to pair up the right way can seek each other out and collect together into drops that are internally self-organized to facilitate the growth of larger pairable molecules.

“In essence, the liquid crystal phase condensation selects the appropriate molecular components, and with the right chemistry would evolve larger molecules tuned to stabilize the liquid crystal phase. If this is correct, the linear polymer shape of DNA itself is a vestige of formation by liquid crystal order.”

Symptoms of Mesothelioma of the Lungs


Mesothelioma of the lungs is called pleural mesothelioma. Symptoms of mesothelioma may not appear for 20 to 40 years after exposure and sometimes longer. Around 3000 people are diagnosed with malignant mesothelioma each year. Roughly 2/3 of mesothelioma cases are Pleural mesothelioma. Pleural mesothelioma occurs in the lining of the lungs called the pleural membrane.

Pleural mesothelioma is caused by the inhalation of asbestos fibers. Once the asbestos fibers are brought into the lungs, they find their way to the pleural membrane. Over time, typically 20 years and more, the accumulation of these fibers begins to scare the lining of the lungs. The scaring causes tumor growth on the lungs and ultimately cancer. The cancerous cells prevent the creation of healthy cells and ultimately the pleural member thickens. As a result, lung capacity is reduced and fluid begins to fill between the pleural layers.

Symptoms of mesothelioma of the lungs (Pleural Mesothelioma) include:
  • Dry or raspy cough
  • Night sweats
  • Fever
  • Unexplained weight loss (10% or more)
  • Difficulty in swallowing
  • Fatigue
  • Persistent pain in the chest
  • Painful breathing
  • Coughing up blood
  • Wheezing
  • Shortness of breath (even during rest)
  • Lumps under the skin on the chest

Mesothelioma: Facts about Mesothelioma


Mesothelioma is a form of cancer that affects the mesothelial cells of the body. These are the cells that make up the outer lining for the body’s major organs, such as the heart, lungs and stomach. These linings are referred to as the mesothelium and this is how the cancer got its name.

Pleural Mesothelioma

The pleura are the tissue that covers and lines the lungs. These are referred to by the medical community as pleural membranes. The pleura are fibrous membranes and the space between them is the pleural space. The pleural protect the lungs by producing a lubricant that fills the pleural space. This lubricant also allows the lungs to move easily within the chest cavity as we inhale and exhale.

Pleural mesothelioma is the most common type of the disease. Since the lungs are so close to the heart, it is almost always affected. The pericardium is the lining found on the outside of the heart and allows it to move freely within the heart cavity.

The Peritoneum

The peritoneum is the tissue lining the abdomen. Its job is to protect the abdomen’s contents. It produces a fluid that acts as a lubricant so organs within the abdomen may move freely. Peritoneal mesothelioma is cancer of the tissue that lines the abdominal cavity. This form of mesothelioma is rarer than pleural mesothelioma.

Causes of Mesothelioma

Mesothelioma is caused by unprotected exposure to asbestos and affects those who were put at risk for the last 50 years.

Who Gets Mesothelioma

The disease is most common in males who are between the ages of 60 and 70 years old. These men were constantly exposed to asbestos dust and fiber, which caused the mutation of the mesothelioma cells. Mesothelioma takes years to develop, which means early diagnosis is almost impossible.

Others at risk for mesothelioma are those who lived in the same household with someone who was constantly exposed to asbestos. Men carried asbestos dust and fibers into their homes on clothing. It was then breathed in by family members. This put them at risk of contacting mesothelioma and other diseases related to asbestos years after the fact.

Treatment

The success of treatment for mesothelioma isn”t high. The final stages of the disease are fatal. The earlier mesothelioma is diagnosed, the better the prognosis. If you or a member of your immediate family has ever been constantly exposed to asbestos in the workplace, be sure to contact your health care professional to find out exactly what your options are. You may be tested for the disease and get a clear bill of health.

Science committee says NHS must embrace genomic medicine


DNA

The government should bring forward new legislation on genomic medicine, the House of Lords Science and Technology Committee has said.

The committee have published a report on Genomic Medicine which argues that recent developments in genomic science stemming from the sequencing of the human genome represent a unique opportunity for real advances in medical care.

They said the Government should produce a White Paper on genomic medicine and the NHS must take a range of steps to ensure that these advances are realised.

The last White Paper on the issue was published in 2003 and dealt mainly with the diagnosis and management of rare single-gene disorders.

The potential impact of “genomic medicine” has moved on significantly since then and now has implications for patient care across the NHS and a range of common, genetically complex diseases such as diabetes, heart disease and cancer.

Lord Patel, who chaired the Inquiry, said:

“Genomic medicine will clearly have a huge impact on health provision and the NHS in particular over the next few years. It is an ever developing technology that presents both challenges and exciting opportunities for health care.

“The Government must now take the lead on this issue and produce a new White Paper on genomic medicine. It has been six years since the last one and in this area times move on very quickly.

“It is time for a comprehensive statement from the Government on how genomic medicine will be incorporated into the NHS, including details of the extra training doctors and nurses will need in this area.

“We have concerns about the growth of ‘at home’ Direct to Consumer Tests.

“Without proper qualified interpretation results of genetic and genomic tests could cause people to worry unnecessarily and place new demands on NHS services.

“It is time firms offering these tests were required to provide counselling and guidance on interpreting the raw results they provide.”

A range of genetic tests are already being used within the NHS to improve the diagnosis and treatment of a range of common illnesses, the committee said.

However there are several barriers to the translation of new tests from invention through to use within the NHS.

To alleviate these problems, the Committee recommends that the National Institute for Health Research ring-fence funding through a Health Technology Assessment programme to fund research into the use of genomic tests within the NHS, and that the Office for Strategic Coordination of Health Research should be tasked with outlining a strategic vision to overcome the translational barriers identified.

The report also recommends that the Government push for the re-classification of genetic tests within European law from ‘low’ to ‘medium’ risk to ensure that all tests are subject to pre-market review to prove their effectiveness before they are available for use either by the NHS or directly by consumers.

The Committee looks specifically at the growing market for Direct to Consumer Tests (DCTs) and raises concerns about the effect of consumers receiving DCT results via the internet without proper medical advice to put those results in context.

They also point out that because most companies that offer DCTs are based abroad the Advertising Standards Agency has no power to police bogus claims made by DCT providers for their products.

To counter these problems the Committee supports the Human Genetics Commissions work to develop a voluntary code of practice for DCT providers.

The code of practice should require firms to publish details of the effectiveness of the tests they offer. It should also include guidelines for the provision of appropriate pre- and post test counselling to help consumers interpret the results of DCTs.

The Committee found significant inequalities in the provision of genetic services across the NHS, for investigation and management of both rare and common diseases, due to the lack of a national policy on commissioning of genetics services.

Significant changes to the operational systems within the NHS are vital to ensure that an equitable and cost effective service is provided across the country including the need to consolidate laboratory services.

The report recognises that there are privacy concerns about the retention and use of genetic data as well as apprehension about how the data may be used by, for example the insurance industry.

To alleviate privacy concerns the Committee recommends that the Information Commissioner should publish a set of clear guidelines for researchers handling genetic data.

The Committee suggests the Government should work with the Association of British Insurers to draw up a new agreement on the use of genetic tests results for insurance purposes beyond the current moratorium which runs out in 2014.

DNA analysed from early European



Kostenki 14 (Vladimir Gorodnianskiy)
The DNA comes from the skeleton of a male in his twenties

By Paul Rincon
Science reporter, BBC News

Scientists have analysed DNA extracted from the remains of a 30,000-year-old European hunter-gatherer.

Studying the DNA of long-dead humans can open up a window into the evolution of our species (Homo sapiens).

But previous studies of this kind have been hampered by scientists' inability to distinguish between the ancient human DNA and modern contamination.

In Current Biology journal, a German-Russian team details how it was possible to overcome this hurdle.

Svante Paabo, from the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, and colleagues used the latest DNA sequencing techniques to study genetic information from human remains unearthed in 1954 at Kostenki, Russia.

Excavations at Kostenki, on the banks of the river Don in southern Russia, have yielded large concentrations of archaeological finds from the Palaeolithic (roughly 40,000 years ago to 10,000 years ago). Some of the finds date back as far as 45,000 years.

The ironic thing is that our group has been one of those that raised this issue
Professor Svante Paabo, Max Planck Institue

The DNA analysed in this study comes from a male aged 20-25 who was deliberately buried in an oval pit some 30,000 years ago.

Known as the Markina Gora skeleton, it was found lying in a crouched position with fists reaching upwards and a face orientated down towards the dirt. The bones were covered in a pigment called red ochre, thought to have been used in prehistoric funeral rites.

The type of DNA extracted and analysed is that stored in mitochondria - the "powerhouses" of cells. This mitochondrial DNA (mtDNA) is passed down from a mother to her offspring, providing a unique record of maternal inheritance.

Using technology pioneered in the study of DNA from Neanderthal bones, they were able to distinguish between ancient genetic material from the Kostenki male and contamination from modern people who handled the bones, or whose DNA reached the remains by some other means.

Markina Gora/Kostenki 14 (Soviet picture)
The ancient skeleton was unearthed in 1954 at Kostenki in Russia (Courtesy of Vladimir Gorodnyanskiy)

The new approach, developed by Professor Paabo and his colleagues, exploits three features which tend to distinguish ancient DNA from modern contamination. One of these is size; fragments of ancient DNA are often shorter than those from modern sources.

Previous ancient DNA studies used the widespread polymerase chain reaction (PCR) technology. PCR amplifies a few pieces of genetic material, generating thousands to millions of copies of a sequence. But the researchers found many fragments of ancient DNA were too small to be amplified by PCR.

A second characteristic of ancient DNA was its tendency to show particular changes, or mutations, in the genetic sequence at the ends of DNA molecules.

A third feature was a characteristic breakage of molecules at particular positions in the DNA strand.

Trust issues

The apparent ease with which modern DNA can infiltrate ancient remains has led many researchers to doubt even those studies employing the most rigorous methods to weed out contamination by modern genetic material.

"The ironic thing is that our group has been one of those that raised this issue," Professor Paabo told BBC News.

"To take animal studies on cave bears, for example, if we use PCR primers specific for human DNA on cave bear bones, we can retrieve modern human DNA on almost every one. That has made me think: 'how can I trust anything on this'."

Kostenki 14 site (Science)
Large concentrations of Palaeolithic finds have come from Kostenki

Using the new techniques, the researchers were able to sequence the entire mitochondrial genome of the Markina Gora individual.

Future studies like the one in Current Biology could help shed light on whether the humans living in Europe 30,000 years ago are the direct ancestors of modern populations or whether they were replaced by immigrants who introduced farming to the continent several thousand years ago.

The modern gene pool contains a wide variety of mtDNA lineages. Studying these maternal lineages provides scientists with clues to the origins and histories of human populations.

Scientists look for known genetic signatures in order to classify an individual's mtDNA into different types, or "haplogroups". These haplogroups represent major branches on the family tree of Homo sapiens.

Early arrival

The researchers were able to assign the Kostenki individual to haplogroup "U2", which is relatively uncommon among modern populations.

U2 appears to be scattered at low frequencies in populations from South and Western Asia, Europe and North Africa.

Despite its rarity, the very presence of this haplogroup in today's Europeans suggests some continuity between Palaeolithic hunters and the continent's present-day inhabitants, argue the authors of the latest study.

DNA molecular structure (SPL)
Distinguishing ancient DNA from modern has been difficult until now

U2, along with closely related haplogroups such as U5, are among those which could plausibly have arrived in Europe during the Palaeolithic.

Geneticists use well-established techniques to "date" particular genetic events, such as when a haplogroup first diversified. The "U" branch (comprising haplogroups U1, U2, U3 and so on) appears to be more ancient than many other genetic lineages found in Europe.

A recent study found a very high percentage of U types in the skeletal remains of ancient hunter-gatherers from Central Europe compared with later farming immigrants and modern people from the region.

Meanwhile, an analysis last year of mtDNA from 28,000-year-old remains unearthed at Paglicci Cave in Italy showed this individual belonged to haplogroup "H" - the most common type found in modern Europeans.

NeoCounter